| [1] |
Sung H, Siegel RL, Torre LA, et al. Global patterns in excess body weight and the associated cancer burden [J]. CA Cancer J Clin, 2019, 69(2): 88-112.
|
| [2] |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J]. Thyroid, 2016, 26(1): 1-133.
|
| [3] |
杨华, 陈缘, 董志勇, 等. 中国肥胖代谢外科数据库：2020年度报告 [J/CD]. 中华肥胖与代谢病电子杂志, 2021, 7(1): 1-7.
|
| [4] |
Pellegriti G, Frasca F, Regalbuto C, et al. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors [J]. J Cancer Epidemiol, 2013, 2013: 965212.
|
| [5] |
Lim H, Devesa SS, Sosa JA, et al. Trends in Thyroid cancer incidence and mortality in the United States, 1974-2013 [J]. JAMA, 2017, 317(13): 1338-1348.
|
| [6] |
Du L, Li R, Ge M, et al. Incidence and mortality of thyroid cancer in China, 2008-2012 [J]. Chin J Cancer Res, 2019, 31(1): 144-151.
|
| [7] |
Kent WD, Hall SF, Isotalo PA, et al. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease [J]. Cmaj, 2007, 177(11): 1357-1361.
|
| [8] |
Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic"—screening and overdiagnosis [J]. N Engl J Med, 2014, 371(19): 1765-1767.
|
| [9] |
Amphlett B, Lawson Z, Abdulrahman GO, et al. Recent trends in the incidence, geographical distribution, and survival from thyroid cancer in Wales, 1985-2010 [J]. Thyroid, 2013, 23(11): 1470-1478.
|
| [10] |
Morris LG, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis [J]. Am J Surg, 2010, 200(4): 454-461.
|
| [11] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016; 66(2): 115-132.
|
| [12] |
Xhaard C, Rubino C, Cléro E, et al. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: a population-based case-control study [J]. Am J Epidemiol, 2014, 180(10): 1007-1017.
|
| [13] |
Fiore E, Rago T, Provenzale MA, et al. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role [J]. Endocr Relat Cancer, 2009, 16(4): 1251-1260.
|
| [14] |
Schmid D, Ricci C, Behrens G, et al. Adiposity and risk of thyroid cancer: a systematic review and meta-analysis [J]. Obes Rev, 2015, 16(12): 1042-1054.
|
| [15] |
Pappa T, Alevizaki M. Obesity and thyroid cancer: a clinical update [J]. Thyroid, 2014, 24(2): 190-199.
|
| [16] |
Harikrishna A, Ishak A, Ellinides A, et al. The impact of obesity and insulin resistance on thyroid cancer: A systematic review [J]. Maturitas, 2019, 125(1): 45-49.
|
| [17] |
Shin HY, Jee YH, Cho ER. Body mass index and incidence of thyroid cancer in Korea: the Korean Cancer Prevention Study-II [J]. J Cancer Res Clin Oncol, 2017, 143(1): 143-149.
|
| [18] |
Hwang Y, Lee KE, Park YJ, et al. Annual Average Changes in adult obesity as a risk factor for papillary thyroid cancer: a large-scale case-control study [J]. Medicine (Baltimore), 2016, 95(9): e2893.
|
| [19] |
Wu C, Wang L, Chen W, et al. Associations between body mass index and lymph node metastases of patients with papillary thyroid cancer: A retrospective study [J]. Medicine (Baltimore), 2017, 96(9): e6202.
|
| [20] |
Kim SK, Woo JW, Park I, et al. Influence of Body Mass Index and Body Surface Area on the Behavior of Papillary Thyroid Carcinoma [J]. Thyroid, 2016, 26(5): 657-666.
|
| [21] |
Kim HJ, Kim NK, Choi JH, et al. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer [J]. Clin Endocrinol (Oxf), 2013, 78(1): 134-140.
|
| [22] |
Harari A, Endo B, Nishimoto S, et al. Risk of advanced papillary thyroid cancer in obese patients [J]. Arch Surg, 2012, 147(9): 805-811.
|
| [23] |
Paes JE, Hua K, Nagy R, et al. The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study [J]. J Clin Endocrinol Metab, 2010, 95(9): 4244-4250.
|
| [24] |
Brito H, Santos AC, Preto J, et al. Obesity and cancer: the profile of a population who underwent bariatric surgery [J]. Obes Surg, 2021, 31(11): 4682-4691.
|
| [25] |
中华人民共和国卫生健康委员会. 甲状腺癌诊疗规范(2018年版) [J/CD]. 中华普通外科学文献(电子版), 2019, 13(01): 1-15.
|
| [26] |
中华医学会内分泌学分会, 中华医学会外科学分会, 中国抗癌协会头颈肿瘤专业委员会, 等. 甲状腺结节和分化型甲状腺癌诊治指南 [J]. 中国肿瘤临床, 2012, 39(17): 1249-1272.
|
| [27] |
中国医师协会外科医师分会甲状腺外科医师委员会, 中国研究型医院学会甲状腺疾病专业委员会, 中国医学装备协会外科装备分会甲状腺外科装备委员会. 超声引导下甲状腺结节细针穿刺活检专家共识及操作指南(2018版) [J]. 中国实用外科杂志, 2018, 38(3): 241-244.
|
| [28] |
Guan B, Chen Y, Yang J, et al. Effect of bariatric surgery on thyroid function in obese patients: a systematic review and Meta-Analysis [J]. Obes Surg, 2017, 27(12): 3292-305.
|
| [29] |
中华医学会外科学分会甲状腺及代谢外科学组, 中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 中国肥胖及2型糖尿病外科治疗指南(2019版) [J]. 中国实用外科杂志. 2019; 39(4): 301-306.
|
| [30] |
刘烺飚, 张鹏. 超级肥胖症减重手术的围手术期管理 [J/CD]. 中华肥胖与代谢病电子杂志, 2019, 5(4): 187-190.
|
| [31] |
Chereau N, Vuillermet C, Tilly C, et al. Hypocalcemia after thyroidectomy in patients with a history of bariatric surgery [J]. Surg Obes Relat Dis, 2017, 13(3): 484-490.
|
| [32] |
Droeser RA, Ottosson J, Muth A, et al. Hypoparathyroidism after total thyroidectomy in patients with previous gastric bypass [J]. Langenbecks Arch Surg, 2017, 402(2): 273-280.
|
| [33] |
Wood SG, Kumar SB, Dewey E, et al. Safety of concomitant cholecystectomy with laparoscopic sleeve gastrectomy and gastric bypass: a MBSAQIP analysis [J]. Surg Obes Relat Dis, 2019, 15(6): 864-870.
|
| [34] |
Clapp B, Lee I, Liggett E, et al. Are concomitant operations during bariatric surgery safe? an Analysis of the MBSAQIP Database [J]. Obes Surg, 2020, 30(11): 4474-4481.
|
| [35] |
Ebrahim MAK, AlSanea O, Al-Terki AE. Combined surgical approach for obstructive sleep apnea patient [J]. Case Rep Otolaryngol, 2018, 2018, 4798024.
|
| [36] |
Krivan MS, Giorga A, Barreca M, et al. Concomitant ventral hernia repair and bariatric surgery: a retrospective analysis from a UK-based bariatric center [J]. Surg Endosc, 2019, 33(3): 705-710.
|
| [37] |
Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art [J]. Nat Rev Gastroenterol Hepatol, 2017, 14(3): 160-169.
|
| [38] |
Antoniou SA, Antoniou GA, Koch OO, et al. Laparoscopic versus open obesity surgery: a meta-analysis of pulmonary complications [J]. Dig Surg, 2015, 32(2): 98-107.
|
| [39] |
Weller WE, Rosati C. Comparing outcomes of laparoscopic versus open bariatric surgery [J]. Ann Surg, 2008, 248(1): 10-15.
|
| [40] |
Yin J, Hou X. Complications of laparoscopic versus open bariatric surgical interventions in obesity management [J]. Cell Biochem Biophys, 2014, 70(2): 721-728.
|
| [41] |
Parrott J, Frank L, Rabena R, et al. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients [J]. Surg Obes Relat Dis, 2017, 13(5): 727-741.
|
| [42] |
Benmiloud F, Godiris-Petit G, Gras R, et al. Association of Autofluorescence-Based Detection of the Parathyroid Glands During Total Thyroidectomy With Postoperative Hypocalcemia Risk: Results of the PARAFLUO Multicenter Randomized Clinical Trial [J]. JAMA Surg, 2020, 155(2): 106-112.
|
| [43] |
Dequanter D, Shahla M, Deniz Y, et al. Recalcitrant hypocalcemia after total thyroidectomy and bariatric surgery [J]. Bent, 2016, 12(3): 207-209.
|
| [44] |
Manco M, Nanni G, Tondolo V, et al. Hypocalcemia complicating near-total thyroidectomy in patients with coexisting lipid malabsorption due to biliopancreatic diversion [J]. Obes Surg, 2004, 14(10): 1429-1434.
|
| [45] |
中华医学会内分泌学分会, 中华医学会外科学分会, 中国抗癌协会头颈肿瘤专业委员会, 等. 甲状腺结节和分化型甲状腺癌诊治指南 [J]. 中华内分泌代谢杂志. 2012, 28(10): 779-797.
|
| [46] |
Papoian V, Ylli D, Felger EA, et al. Evaluation of thyroid hormone replacement dosing in overweight and obese patients after a thyroidectomy [J]. Thyroid, 2019, 29(11): 1558-1562.
|
| [47] |
Raftopoulos Y, Gagné DJ, Papasavas P, et al. Improvement of hypothyroidism after laparoscopic Roux-en-Y gastric bypass for morbid obesity [J]. Obes Surg, 2004, 14(4): 509-513.
|
| [48] |
Sawaya RA, Jaffe J, Friedenberg L, et al. Vitamin, mineral, and drug absorption following bariatric surgery [J]. Curr Drug Metab, 2012, 13(9): 1345-1355.
|
| [49] |
Smith A, Henriksen B, Cohen A. Pharmacokinetic considerations in Roux-en-Y gastric bypass patients [J]. Am J Health Syst Pharm, 2011, 68(23): 2241-2247.
|